Browsing: drug affordability

In a daring initiative to tackle soaring healthcare expenses, the US government is setting its sights on pharmaceutical companies, demanding significant reductions in drug prices. At the same time, India’s thriving generics market stands resilient and largely unaffected, prompting intriguing discussions about the shifting landscape of global pricing dynamics.

Brazil’s groundbreaking update to drug pricing regulations is shaking up the pharmaceutical landscape! Companies are now required to present stronger evidence showcasing their products’ effectiveness and cost-efficiency. This pivotal change could transform market dynamics and enhance access to vital medications throughout the country.